Literature DB >> 23625397

Phosphopeptide enrichment using offline titanium dioxide columns for phosphoproteomics.

Li-Rong Yu1, Timothy Veenstra.   

Abstract

Identification of phosphoproteins or phosphopeptides as cancer biomarkers is an emerging field in phosphoproteomics. Owing to the low stoichiometric nature of protein phosphorylation, phosphoproteins or phosphopeptides must be enriched prior to downstream mass spectrometry analysis. Titanium dioxide (TiO2) has been prevalently used to enrich phosphopeptides from complex proteome samples due to its high affinity for phosphopeptides, and the method is straightforward. In this protocol, an offline phosphopeptide enrichment procedure using TiO2 columns is described. Peptides from a proteome lysate are loaded onto a TiO2 column in an acidic environment, followed by column washing with aqueous, organic, and ammonium glutamate (NH4Glu) buffers at acidic conditions. Phosphopeptides are eluted using an ammonia solution at high pH. Use of NH4Glu significantly reduces nonspecific bindings while a high recovery rate (84 %) of phosphopeptides is retained. The method is optimized for large-scale phosphoproteomic analysis and phosphoprotein biomarker discovery starting from sub-milligram or milligrams of proteome samples.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23625397     DOI: 10.1007/978-1-62703-360-2_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Human cytomegalovirus pUL97 kinase induces global changes in the infected cell phosphoproteome.

Authors:  Adam Oberstein; David H Perlman; Thomas Shenk; Laura J Terry
Journal:  Proteomics       Date:  2015-05-12       Impact factor: 3.984

2.  CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation.

Authors:  Jian Huang; Luxin Wang; Yunli Shen; Shengqi Zhang; Yaqun Zhou; Jimin Du; Xiue Ma; Yi Liu; Dandan Liang; Dan Shi; Honghui Ma; Li Li; Qi Zhang; Yi-Han Chen
Journal:  Nat Commun       Date:  2022-07-30       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.